Markets

Intersect ENT (XENT) Catches Eye: Stock Moves Up 11.3%

Intersect ENT, Inc. ( XENT ) was a big mover last session, as its shares rose over 11% on the day. The upside was driven by the company's FDA submission seeking approval for expanded use of its PROPEL mini product. This also led to far more shares changing hands than in a normal session. Yesterday's rally breaks the downtrend for the company since Sep 17, as the stock is now down almost 24%.

Over the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Intersect ENT currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Another favorably ranked med instruments stock is ABIOMED, Inc. ( ABMD ) with a Zacks Rank #1 (Strong Buy).

Is XENT going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

INTERSECT ENT (XENT): Free Stock Analysis Report

ABIOMED INC (ABMD): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ABMD XENT

Other Topics

Investing Stocks

Latest Markets Videos